Angiolink Corporation

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 50.0

Forward Citations = 3,139

Loading Chart...

5 inventors (with patents filed for the assignee):

Glenn Kanner (6 out of 11 patents)

Kenneth Arden Eliasen (3 out of 38 patents)

Steve Bollinger (2 out of 5 patents)

4. Steve J Tallarida (1 out of 3 patents)

5. Steven J Tallarida (1 out of 66 patents)

6 patents: Sort by Forward Citations

1. 6767356 - Advanced wound site management systems and methods (2004-07-27),

2. 6755842 - Advanced wound site management systems and methods (2004-06-29),

3. 6533762 - Advanced wound site management systems and methods (2003-03-18),

4. 6506210 - Wound site management and wound closure device (2003-01-14),

5. 6348064 - Wound site management and wound closure device (2002-02-19),

6. 6322580 - Wound site management and wound closure device (2001-11-27),

Company Overview

Angiolink Corporation is a leading medical device company specializing in vascular access products for interventional procedures. With a focus on innovation and patient safety, Angiolink's products are designed to improve the efficiency and outcomes of vascular access procedures, such as angioplasty and stenting. The company's mission is to provide healthcare professionals with the tools they need to deliver high-quality care to their patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#9 in Taunton, MA

#2,548 in Massachusetts

#45,030 in US

Taunton, MA, United States of America